Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
ID: 347494Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347494

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-098.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)" aimed at fostering advanced genomic research through multidisciplinary projects that address significant biomedical challenges. The program seeks applications from a diverse range of eligible organizations, including historically black colleges, tribal colleges, and community-based organizations, with a focus on innovative solutions in genomic science and medicine. Each awarded project can receive up to $1.5 million per year for a maximum duration of ten years, with applications due by June 23, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-098.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-098-Full-Announcement.html
    PAR-23-098.html
    The Centers of Excellence in Genomic Science (CEGS) program, managed by the National Institutes of Health (NIH), aims to foster advanced genomic research by supporting multidisciplinary, innovative projects to tackle biomedical challenges. This funding opportunity encourages applications from various eligible organizations, particularly those committed to expanding the diversity of genomic science participants. Each CEGS project is expected to deliver significant advancements in genomic methodologies, tools, and applications for knowledge sharing, including educational outreach for diverse groups. Applications must address the critical features of innovation, significance, and integration, with funding opportunities available for new and renewal applications. With a budget cap of $1.5 million per year for a maximum duration of ten years, successful proposals should demonstrate strong scientific merit and practical applicability of their findings. The program emphasizes sharing resources and data to advance genomics research nationwide. Collaborative teams must demonstrate a cohesive approach, effective project management, and clear pathways for educational and outreach activities. The NIH ensures rigorous evaluation of applications based on the outlined criteria to allocate funding effectively, fostering transformative genomic research that addresses current and future health challenges.
    Similar Opportunities
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)" aimed at enhancing workforce diversity in genomics research. This initiative seeks to support educational programs that provide research experiences and skills development for individuals from diverse and underrepresented backgrounds, particularly targeting undergraduate and post-baccalaureate trainees. The program emphasizes the importance of mentorship and innovative educational strategies to foster a diverse research community, ultimately driving advancements in biomedical sciences and improving health equity. Interested applicants can find more information and submit proposals through Grants.gov, with a funding ceiling of $325,000 and a submission deadline of January 27, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the "Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)" grant, aimed at establishing a Sequencing Center to support a new population screening network. This initiative focuses on providing genomic sequencing services for 20,000 study participants, particularly targeting actionable conditions identified by the CDC, such as hereditary breast and ovarian cancer and Lynch syndrome, while ensuring inclusive recruitment from health disparity populations. The program emphasizes collaboration with community stakeholders and primary care providers to enhance genomic testing and follow-up care, ultimately aiming to integrate genomic medicine into primary care and address health disparities. Interested applicants should note that the total budget for the first year is $600,000, with escalating costs for subsequent years, and the application deadline is December 2, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-023.html.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NHGRI Short Courses for Genomics-Related Research Education (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NHGRI Short Courses for Genomics-Related Research Education" (R25), aimed at enhancing research education in genomics. This initiative supports the development of advanced short courses focused on skills development in genome sciences, genomic medicine, and the ethical, legal, and social implications of genomics, targeting both emerging and established researchers. Funded projects may receive up to $150,000 annually for a maximum duration of five years, with applications due by January 25, 2025. Interested applicants can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov or through the provided link to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-095.html.
    Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for a Cooperative Agreement to establish a Coordinating Center focused on population genomic screening in primary care settings. This initiative aims to evaluate and implement screening for 4-7 common genomic conditions, emphasizing community engagement and the integration of healthcare equity, particularly for underserved populations. The program, managed by the National Human Genome Research Institute (NHGRI), seeks to develop frameworks for effective genomic screening practices while adhering to NIH’s data sharing and clinical trial registration policies. Interested applicants can access the full announcement at NIH Grants, with a funding commitment of $5.75 million over five years and an application deadline of December 2, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.